Figure 6
From: The disulfidptosis-related signature predicts prognosis and immune features in glioma patients
Correlation between the disulfidptosis-related signature and immune checkpoint genes. (A) Expression of immune checkpoint genes between low‐ and high‐risk groups. (B) Expression of PD-1 (PDCD1) and PD-L1 (CD274) between low‐ and high‐risk groups. Correlation between disulfidptosis-related signature risk score and the expression of PD-1 and PD-L1. ****p < 0.0001.
